Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel calcitonin gene-related peptide (CGRP) receptor antagonists disclosed by Merck & Co.

Jan. 23, 2009

Vitamin effect on homocystine levels does not affect Abeta levels in stroke patients

Jan. 22, 2009

Merck & Co. divulge new gamma-secretase modulators for Alzheimer's disease

Jan. 22, 2009

AVI reports positive results from phase I trial of AVI-4658 for DMD

Jan. 22, 2009

Parkinson's disease drug Trerief obtains marketing approval in Japan

Jan. 22, 2009

Alexza initiates phase IIb clinical trial of Staccato loxapine in migraine

Jan. 22, 2009

Novel mGluR5 receptor modulators with antipsychotic properties developed at GSK

Jan. 22, 2009

Recent Roche patent reports new antipsychotic tachykinin NK3 receptor antagonists

Jan. 22, 2009

Auris Medical commences phase IIb AM-111 trial in hearing loss

Jan. 21, 2009

Roche discloses novel tachykinin NK3 receptor antagonists

Jan. 21, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...